| 1. | | Recruiting | Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorder or Myelodysplastic Syndrome
Conditions: Polycythemia Vera; Essential Thrombocythemia; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ... |
| 2. | | Recruiting | Imatinib Mesylate in Treating Patients With Myelofibrosis
Conditions: Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia; Chronic Myelomonocytic Leukemia |
| 3. | | Recruiting | Therapy of Hypereosinophilic Syndrome, Polycythemia Vera, Atypical CML or CMML with PDGF-R Fusion Genes, or Mastocytosis with Gleevec
Conditions: Chronic Myelomonocytic Leukemia; Chronic Myeloid Leukemia; Polycythemia Vera; Hypereosinophilic Syndrome; Mastocytosis |
| 4. | | Recruiting | Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 5. | | Recruiting | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 6. | | Recruiting | Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer; ... |
| 7. | | Recruiting | Sirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: chronic myeloproliferative disorders; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 8. | | Recruiting | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Conditions: adult solid tumor; fever, sweats, and hot flashes; hematopoietic and lymphoid cancer; Infection; Neutropenia |
| 9. | | Recruiting | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Conditions: acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease |
| 10. | | Recruiting | Donor Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 11. | | Recruiting | Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 12. | | Recruiting | Donor Bone Marrow Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 13. | | Recruiting | Peripheral Stem Cell Transplantation Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
Conditions: Breast Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; skin tumor |
| 14. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 15. | | Recruiting | Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 16. | | Recruiting | Safety and Efficacy of Hum195/rGel in Patients with Advanced Myeloid Malignancies
Conditions: Myelodysplastic Syndromes; Leukemia, Myelocytic, Acute; Anemia, Refractory, with Excess of Blasts; Myeloproliferative Disorders |
